Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.3.2 instead of v3.3.1, indicating a minor version update. This change does not alter study content or user-facing functionality.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page; no changes to study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check23 days agoChange DetectedRemoved the government funding lapse notice banner from the page. The study details and trial information remain unchanged.SummaryDifference0.1%

- Check31 days agoChange DetectedResults Submitted is now displayed in place of No Results Posted, indicating that the trial results have been submitted for publication.SummaryDifference0.0%

- Check38 days agoChange DetectedNo additions or deletions were detected in the Study Details page for NCT03602859; the content and layout appear unchanged.SummaryDifference0.2%

- Check67 days agoChange DetectedAdds v3.2.0 and removes a specific disease resource (Ovarian cancer); minor content scope change and update history.SummaryDifference0.2%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.